Genitourinary Cancer

Top Story

AACR: Advances in cancer research, medical funding allow for ‘phenomenal’ progress

AACR: Advances in cancer research, medical funding allow for ‘phenomenal’ progress
October 17, 2017

Oncology leaders who participated in an American Association for Cancer Research webinar this afternoon highlighted several advances in cancer research and emphasized the importance of robust medical research funding.

Webinar participants also provided updates on the seventh annual AACR Cancer Progress Report, released last month. The report — titled “Harnessing Research Discoveries to Save Lives” — provided a snapshot of cancer progress this year, and also offered recommendations to increase public understanding and advocate for increased federal funding.

In the Journals

Oral HPV affects 1 in 9 men in US

October 16, 2017
The prevalence of oral HPV infection was higher among men than women in the United States, with approximately 11 million men and 3.2 million women affected nationwide…
FDA News

FDA grants priority review to Cabometyx for advanced renal cell carcinoma

October 16, 2017
The FDA granted priority review to cabozantinib for first-line treatment of advanced renal cell carcinoma, according to the drug’s manufacturer. A supplemental new…

NIH collaboration aims to identify, validate immunotherapy biomarkers

October 13, 2017
NIH launched the Partnership for Accelerating Cancer Therapies, a 5-year public-private research collaboration. The $215 million effort is part of the national cancer…
More Headlines »
CME

What's Hot in Melanoma? Highlights from the HemOnc Today Melanoma and Cutaneous Malignancies 2017 Meeting

This activity is supported by an educational grant from Merck & Co, Inc.

The development and integration of targeted therapies, as well as immunotherapies, into clinical strategies for the…
More »
Video
Meeting News

VIDEO: Late health problems becoming less common in childhood cancer survivors

June 4, 2017
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised…
More »
Advertisement
Advertisement